Skip to Main Content

Author Details

Connor Bell
Dana-Farber Cancer Institute
2018
16
8
PMIDPaper TitleJournal TitlePublished Year
36681680Epigenomic charting and functional annotation of risk loci in renal cell carcinoma.Nat Commun2023
37857693Author Correction: A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.Nat Commun2023
37612286A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.Nat Commun2023
36383107Assessing the Association of Solitary Confinement Ban With Adolescent Self-Harm in New York City Jails.J Correct Health Care2022
35731919The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response.Cancer Res2022
35603787Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome.JCI Insight2022
35562350MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.Nat Commun2022
34699744Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms.Am J Hum Genet2021
33785741Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.Nat Commun2021
32690948Prostate cancer reactivates developmental epigenomic programs during metastatic progression.Nat Genet2020
32041509Clinical Outcomes of Specialized Treatment Units for Patients With Serious Mental Illness in the New York City Jail System.Psychiatr Serv2020
32004450Allele-Specific QTL Fine Mapping with PLASMA.Am J Hum Genet2020
30996073A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).Clin Cancer Res2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
30092737Boundary-Spanning Care: Reducing Psychiatric Rehospitalization and Self-Injury in a Jail Population.J Correct Health Care2018
29909987A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer.Cell2018
  • 1 - 16 of 16

Recommended Authors

Hui Li
Magee-Womens Research Institute
Career Start Year 2018
Number of shared co-authors 9
Sinja Taavitsainen
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2018
Number of shared co-authors 3
Stanley Zhou
Princess Margaret Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 21
Junjie T Hua
School of Public Health, Sun Yat-sen University
Career Start Year 2016
Number of shared co-authors 37
Xiaoyu Wang
Fred Hutchison Cancer Center
Career Start Year 2015
Number of shared co-authors 3
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 14
Veronica Y Sabelnykova
Ontario Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 29
Jing Li
Center for Translational Medicine, Second Military Medical University
Career Start Year 2014
Number of shared co-authors 8
James R Hawley
Princess Margaret Cancer Research Centre
Career Start Year 2014
Number of shared co-authors 22
Sujun Chen
Princess Margaret Cancer Center/University Health Network
Career Start Year 2014
Number of shared co-authors 31
Tokhir Dadaev
The Institute of Cancer Research
Career Start Year 2011
Number of shared co-authors 6
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 10
Paul Lloyd
Bluestar Genomics Inc.
Career Start Year 2010
Number of shared co-authors 14
Suhn K Rhie
Keck School of Medicine of USC
Career Start Year 2009
Number of shared co-authors 4
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 23
Alfonso Urbanucci
Northwestern University Feinberg School of Medicine Chicago
Career Start Year 2008
Number of shared co-authors 16
Alessandro Romanel
University of Trento
Career Start Year 2008
Number of shared co-authors 3
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 10
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 5
Gong-Hong Wei
Fudan University Shanghai Cancer
Career Start Year 2004
Number of shared co-authors 8
Joachim Weischenfeldt
University of Copenhagen
Career Start Year 2004
Number of shared co-authors 13
Daniel Leongamornlert
Oncogenetics Team The Institute of Cancer Research London UK.
Career Start Year 2003
Number of shared co-authors 4
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 5
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 13
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 12
Suzanne Kolb
Fred Hutchinson Cancer Research Center
Career Start Year 1999
Number of shared co-authors 7
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 14
Franklin W Huang
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 19
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 23
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 13

Collaborators

Matthew L Freedman
Dana-Farber Cancer Institute
Co-authored papers 13
Mark M Pomerantz
Dana-Farber Cancer Institute
Co-authored papers 13
Edward O'Connor
Dana-Farber Cancer Institute
Co-authored papers 10
Sylvan C Baca
Co-authored papers 6
Alexander Gusev
The Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute
Co-authored papers 5
Eva Corey
University of Washington School of Medicine
Co-authored papers 4
Leigh Ellis
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 3
Bogdan Pasaniuc
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
David Y Takeda
Co-authored papers 3
Rosario I Corona
Cedars-Sinai Medical Center
Co-authored papers 3
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 3
Myles Brown
Co-authored papers 3
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers 2
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 2
Colm Morrissey
Co-authored papers 2
Massimo Loda
Weill Medical College of Cornell University
Co-authored papers 2
Nadia Boufaied
Research Institute of the McGill University Health Centre
Co-authored papers 2
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 2
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 1
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 1
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 1
Susmita G Ramanand
UT Southwestern Medical Center
Co-authored papers 1
Lewyn Li
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 1
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 1
Robert G Bristow
University of Toronto
Co-authored papers 1
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers 1
Ada Wong
University Health Network
Co-authored papers 1
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
Yang Liu
Veracyte inc.
Co-authored papers 1
R Jeffrey Karnes
Mayo Clinic
Co-authored papers 1
Release 1.2